{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T05:41:01Z","timestamp":1654580461599},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Potent MCL1 inhibitors are showing strong anticancer activity in preclinical models of hematologic cancers, especially when given in combination with other therapies. The drugs are now in phase I testing, with initial clinical results expected soon<\/jats:p>","DOI":"10.1158\/2159-8290.cd-nd2019-002","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:53:40Z","timestamp":1554328420000},"page":"572-572","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting MCL1, Companies Aim to Unblock Apoptosis"],"prefix":"10.1158","volume":"9","member":"1086","published-online":{"date-parts":[[2019,5,1]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/9\/5\/572\/1840859\/572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/9\/5\/572\/1840859\/572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T01:59:03Z","timestamp":1654567143000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/9\/5\/572\/42005\/Targeting-MCL1-Companies-Aim-to-Unblock"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,1]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nd2019-002","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}